Literature DB >> 31152086

The -7 chromosomal abnormalities with signs of myelodysplasia in chronic myeloid leukemia as a major red signal.

Emilie Cayssials1, François Guilhot1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31152086      PMCID： PMC6545827          DOI： 10.3324/haematol.2019.217034

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.

Authors:  M K Andersen; J Pedersen-Bjergaard; L Kjeldsen; I H Dufva; K Brøndum-Nielsen
Journal:  Leukemia       Date:  2002-07       Impact factor: 11.528

2.  Cytogenetics in CML: more important than you think.

Authors:  François Guilhot
Journal:  Blood       Date:  2016-06-02       Impact factor: 22.113

3.  Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

Authors:  Ghayas C Issa; Hagop M Kantarjian; Graciela Nogueras Gonzalez; Gautam Borthakur; Guilin Tang; William Wierda; Koji Sasaki; Nicholas J Short; Farhad Ravandi; Tapan Kadia; Keyur Patel; Raja Luthra; Alessandra Ferrajoli; Guillermo Garcia-Manero; Mary Beth Rios; Sara Dellasala; Elias Jabbour; Jorge E Cortes
Journal:  Blood       Date:  2017-08-23       Impact factor: 22.113

4.  Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.

Authors:  Michael J Groves; Mark Sales; Lee Baker; Michael Griffiths; Norman Pratt; Sudhir Tauro
Journal:  Cancer Genet       Date:  2011-01

5.  Myelodysplastic syndrome with Ph negative monosomy 7 chromosome following transient bone marrow dysplasia during imatinib treatment for chronic myeloid leukemia.

Authors:  Kaori Karimata; Masayoshi Masuko; Takashi Ushiki; Takashi Kozakai; Yasuhiko Shibasaki; Toshio Yano; Takashi Abe; Masato Moriyama; Ken Toba; Tatsuo Furukawa; Yoshifusa Aizawa
Journal:  Intern Med       Date:  2011-03-01       Impact factor: 1.271

6.  Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST.

Authors:  Vincenzo Pitini; Carmela Arrigo; Maria Grazia Sauta; Giuseppe Altavilla
Journal:  Leuk Res       Date:  2009-05-13       Impact factor: 3.156

7.  Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Authors:  Wei Wang; Jorge E Cortes; Guilin Tang; Joseph D Khoury; Sa Wang; Carlos E Bueso-Ramos; Joseph A DiGiuseppe; Zi Chen; Hagop M Kantarjian; L Jeffrey Medeiros; Shimin Hu
Journal:  Blood       Date:  2016-03-22       Impact factor: 22.113

8.  Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.

Authors:  Ewa M Wasilewska; Barbara Panasiuk; Michał Gniot; Anna Sawicka; Katarzyna Kozłowska; Krzysztof Lewandowski; Janusz Kłoczko; Alina T Midro
Journal:  Cancer Genet       Date:  2017-04-28

9.  Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Authors:  Audrey Bidet; Stéphanie Dulucq; Thomas Smol; Alice Marceau-Renaut; Stéphane Morisset; Valérie Coiteux; Marie-Pierre Noël-Walter; Franck-Emmanuel Nicolini; Isabelle Tigaud; Isabelle Luquet; Stéphanie Struski; Baptiste Gaillard; Dominique Penther; Sylvie Tondeur; Nathalie Nadal; Eric Hermet; Lauren Véronèse; Delphine Réa; Carine Gervais; Olivier Theisen; Christine Terré; Pascale Cony-Makhoul; Christine Lefebvre; Jean-Baptiste Gaillard; Isabelle Radford; Anne-Laure Vervaeke; Carole Barin; Elise Chapiro; Florence Nguyen-Khac; Gabriel Etienne; Claude Preudhomme; François Xavier Mahon; Catherine Roche-Lestienne
Journal:  Haematologica       Date:  2018-12-20       Impact factor: 9.941

Review 10.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.